Short-term traders can look to buy the stock now or on dips for a possible target of Rs 2,380 in the next 1-2 months which will surpass its current 52-week high of Rs 2,379 recorded back in November 2021, suggest experts.
Amish Shah turns bullish on pharma, remains cautious on IT
Indian equities are poised for a constructive phase, with strategists anticipating earnings acceleration and a potential revival in foreign investor interest. While near-term earnings surprises